Jens Christian Højland Larsen

Title: Jens Christian Højland Larsen: Innovator in Phosphodiesterase Inhibitors

Introduction

Jens Christian Højland Larsen is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of medicinal chemistry, particularly in the development of phosphodiesterase inhibitors. With a total of 4 patents, his work focuses on innovative compounds that have therapeutic applications.

Latest Patents

Larsen's latest patents include novel biaryl phosphodiesterase inhibitors. These compounds exhibit phosphodiesterase inhibitory activity and are described by a general formula that includes various defined substituents. Their potential use as therapeutic agents in treating inflammatory diseases and conditions is a key aspect of his research. Another significant patent involves [1,2,4]triazolopyridines, which are also identified as phosphodiesterase inhibitors. This invention highlights the therapeutic potential of these compounds in addressing inflammatory diseases.

Career Highlights

Larsen is currently associated with Leo Pharma A/S, a company known for its focus on dermatology and other therapeutic areas. His work at Leo Pharma has allowed him to contribute to the advancement of treatments that improve patient outcomes.

Collaborations

Throughout his career, Larsen has collaborated with talented individuals such as Simon Feldbæk Nielsen and Jakob Felding. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Jens Christian Højland Larsen is a prominent figure in the field of medicinal chemistry, with a focus on phosphodiesterase inhibitors. His innovative patents and collaborations reflect his commitment to advancing therapeutic solutions for inflammatory diseases.